SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-17-004010
Filing Date
2017-04-17
Accepted
2017-04-17 16:30:54
Documents
67
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1376562
2 ex21-1.htm EX-21.1 5508
3 ex31-1.htm EX-31.1 12271
4 ex31-2.htm EX-31.2 12284
5 ex32-1.htm EX-32.1 9224
6 ex32-2.htm EX-32.2 9053
7 image_001.jpg GRAPHIC 9550
8 image_002.jpg GRAPHIC 24570
  Complete submission text file 0001493152-17-004010.txt   4702882

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE obmp-20161231.xml EX-101.INS 561719
10 XBRL SCHEMA FILE obmp-20161231.xsd EX-101.SCH 47364
11 XBRL CALCULATION FILE obmp-20161231_cal.xml EX-101.CAL 53966
12 XBRL DEFINITION FILE obmp-20161231_def.xml EX-101.DEF 193830
13 XBRL LABEL FILE obmp-20161231_lab.xml EX-101.LAB 350090
14 XBRL PRESENTATION FILE obmp-20161231_pre.xml EX-101.PRE 283870
Mailing Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809
Business Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809 225-227-2384
OncBioMune Pharmaceuticals, Inc (Filer) CIK: 0001362703 (see all company filings)

IRS No.: 202590810 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52218 | Film No.: 17764861
SIC: 2834 Pharmaceutical Preparations